185 related articles for article (PubMed ID: 15916295)
1. Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient.
Holcomb JB; Hoots K; Moore FA
Mil Med; 2005 Apr; 170(4):287-90. PubMed ID: 15916295
[TBL] [Abstract][Full Text] [Related]
2. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy.
Gowers CJ; Parr MJ
Anaesth Intensive Care; 2005 Apr; 33(2):196-200. PubMed ID: 15960401
[TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII for non-hemophiliac bleeding patients.
Uhlmann EJ; Eby CS
Curr Opin Hematol; 2004 May; 11(3):198-204. PubMed ID: 15257021
[TBL] [Abstract][Full Text] [Related]
4. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
5. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
Grinţescu I; Tulbure D; Mirea L
Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
[TBL] [Abstract][Full Text] [Related]
6. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
Bauzá G; Hirsch E; Burke P; Quillen K
Transfusion; 2007 Apr; 47(4):749-51. PubMed ID: 17381636
[No Abstract] [Full Text] [Related]
7. Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding.
Ho AM; Dion PW; Karmakar MK
Anesthesiology; 2003 Apr; 98(4):1025-6; author reply 1026-7. PubMed ID: 12657873
[No Abstract] [Full Text] [Related]
8. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
[TBL] [Abstract][Full Text] [Related]
9. The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury.
Christians K; Brasel K; Garlitz J; Abu-Hajir M; Gottschall J
J Trauma; 2005 Sep; 59(3):742-6. PubMed ID: 16361923
[No Abstract] [Full Text] [Related]
10. Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma.
Holcomb JB
J Trauma; 2005 Jun; 58(6):1298-303. PubMed ID: 15995488
[TBL] [Abstract][Full Text] [Related]
11. [Isolated acquired factor VII deficiency in patient with severe head trauma: use of factor VII (factor VII-LFB].
Meaudre E; Kenane N; Kaiser E; Gaillard PE; Saillol A; Cantais E; Palmier B
Ann Fr Anesth Reanim; 2005; 24(11-12):1383-6. PubMed ID: 16099130
[TBL] [Abstract][Full Text] [Related]
12. Role of recombinant activated factor VII in the management of life-threatening coagulopathic bleeding.
Gibbs N
Anaesth Intensive Care; 2005 Apr; 33(2):163-4. PubMed ID: 15960396
[No Abstract] [Full Text] [Related]
13. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant factor VIIa in infants with severe coagulopathy.
Fontaine MJ; Lazarchick J; Taylor S; Annibale D
J Perinatol; 2004 May; 24(5):310-1. PubMed ID: 15116125
[TBL] [Abstract][Full Text] [Related]
15. Indications for use of recombinant factor VIIa: a case study with implications for research.
Moeller MS
J Trauma Nurs; 2006; 13(4):190-2. PubMed ID: 17263101
[TBL] [Abstract][Full Text] [Related]
16. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
[TBL] [Abstract][Full Text] [Related]
17. Near fatal hemorrhage in traumatic bilateral leg amputation with coagulopathy, acidosis, and hypothermia and salvage therapy with recombinant factor VIIa.
Korte WC; Moor S
J Trauma; 2007 Jul; 63(1):E1-4. PubMed ID: 17622857
[No Abstract] [Full Text] [Related]
18. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
19. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
20. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
Chuansumrit A; Nuntnarumit P; Okascharoen C; Teeraratkul S; Suwansingh S; Supapannachart S
Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
